The Antiphospholipid Syndrome

Publisher Website
Google Scholar
Abstract
The antiphospholipid syndrome, now 13 years old, embraces almost all specialties. After a slow start—possibly because many early descriptions were published largely in the rheumatology literature, the syndrome has become recognised worldwide as a major cause of venous-arterial thrombosis, strokes, valvular disease and recurrent abortion. Its prevalence may soon overtake that of its ‘parent’ disease, Lupus.